Benzinga's Weekend M&A Chatter

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday April 25 to Sunday April 27, 2014:

:

Prestige Brands

announced Friday that it has agreed to acquire OTC healthcare product company Insight Pharmaceuticals for $750 million in cash. Insights high-profile brands include, Monistat and Anacin. The deal is expected to close in H1 of FY 2014. Prestige Brands closed Friday at $32.26, a gain of 18%.

:

Microsoft

announced Friday that it has completed its acquisition of Nokia's

Devices and Services business. The deal was approved by Nokia shareholders and by regulatory authorities worldwide. Former Nokia President and CEO, Stephen Elop, serve as executive vice president of the Microsoft Devices Group, and report directly to Microsoft CEO Satya Nadella. Nokia closed Friday at $7.27, a loss of $0.03. Microsoft gained $0.05, closing at $39.91.

:

US generic drug maker Mylan

has raised its bid for Sweden's Meda to $6.7 billion, or 145 kronor per share, according to a report from

. Meda rejected Mylan's previous bid, for an amount which was not disclosed. Spokespersons for Mylan and Meda declined comment on the current offer. Mylan closed Friday at $52.10, a gain of 3.5%.

:

French President Hollande met with ministers late Sunday evening to discuss bids for French train and power plant builder Alstom

from GE

and Germany's Siemen's

, according to

. Siemen's bid includes a proposal to create "two strong European champions". The German conglomerate, which operates energy, healthcare, industry, infrastructure & cities, equity investments, and financial services units, would acquire Alstom's thermal power, renewable power and grid units, while contributing significant parts of its rail systems operations to Alstom. A meeting between Hollande and GE CEO Jeff Immelt is expected to take place on Monday. GE closed Friday at $26.60, a gain of $0.14. Siemens lost more than 1%, closing at $132.75.

:

Merck

is reportedly in talks to sell its consumer healthcare unity for around $14 billion, according to a report Saturday from

. Sources report bidders include Bayer

and Reckitt Benckiser

. A deal could be announced in the coming week. Merck's consumer healthcare unit includes the popular brands Coppertone and Claritin. Spokespersons for the companies declined comment on the report. Merck closed Friday at $57.24, a loss of $0.29.

:

Shares of Chelsea Therapeutics

were trading more than 10% higher at one point on Friday on no apparent news. A spokesperson for the pharmaceutical company told Benzinga the company continues to pursue launch of Northera and is exploring strategic alternatives, including finding a partner or sale of the company. Chelsea Therapeutics closed Friday at $5.04, a gain of 4%.